Chinese English Japanese Korean

GL Biochem (Shanghai) Ltd

Firmenname:GL Biochem (Shanghai) Ltd
Telefon:21-61263452
E-Mail:ymbetter@glbiochem.com
Nationalität:China
URL: www.glschina.com/
Produkte insgesamt:9981
83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100

Produktkatalog

HIV-1 MN ENV-59;CNDKKFSGKGSCKNVC66H111N21O22S2
HIV-1 MN ENV-6;LGLLMICSATEKLWVC77H129N17O20S2
HIV-1 MN ENV-60;KFSGKGSCKNVSTVQC66H112N20O22S
HIV-1 MN ENV-61;KGSCKNVSTVQCTHGC61H105N21O22S2
HIV-1 MN ENV-62;KNVSTVQCTHGIRPVC69H119N23O21S
HIV-1 MN ENV-68;SLAEEEVVIRSENFTC74H119N19O28
HIV-1 MN ENV-69;EEVVIRSENFTDNAKC74H119N21O28
HIV-1 MN ENV-7;MICSATEKLWVTVYYC84H127N17O23S2
HIV-1 MN ENV-70;IRSENFTDNAKTIIVC75H125N21O25
HIV-1 MN ENV-71;NFTDNAKTIIVHLNEC76H121N21O25
HIV-1 MN ENV-72;NAKTIIVHLNESVQIC74H127N21O23
HIV-1 MN ENV-73;IIVHLNESVQINCTRC74H127N23O23S
HIV-1 MN ENV-74;LNESVQINCTRPNYNC73H117N23O26S
HIV-1 MN ENV-75;VQINCTRPNYNKRKRC79H136N30O22S
HIV-1 MN ENV-76;CTRPNYNKRKRIHIGC79H134N30O20S
HIV-1 MN ENV-77;NYNKRKRIHIGPGRAC77H130N30O19
HIV-1 MN ENV-78;RKRIHIGPGRAFYTTC80H129N27O19
HIV-1 MN ENV-79;HIGPGRAFYTTKNIIC78H122N22O20
HIV-1 MN ENV-8;ATEKLWVTVYYGVPVC84H125N17O22
HIV-1 MN ENV-80;GRAFYTTKNIIGTIRC77H127N23O21
HIV-1 MN ENV-81;YTTKNIIGTIRQAHCC74H123N23O22S
HIV-1 MN ENV-82;NIIGTIRQAHCNISRC70H122N26O21S
HIV-1 MN ENV-83;TIRQAHCNISRAKWNC76H124N28O21S
HIV-1 MN ENV-84;AHCNISRAKWNDTLRC75H121N27O22S
HIV-1 MN ENV-85;ISRAKWNDTLRQIVSC78H131N25O23
HIV-1 MN ENV-86;KWNDTLRQIVSKLKEC83H140N24O24
HIV-1 MN ENV-87;TLRQIVSKLKEQFKNC82H142N24O23
HIV-1 MN ENV-88;IVSKLKEQFKNKTIVC82H143N21O22
HIV-1 MN ENV-89;LKEQFKNKTIVFNQSC83H134N22O24
HIV-1 MN ENV-90;FKNKTIVFNQSSGGDC72H112N20O24
HIV-1 MN ENV-91;TIVFNQSSGGDPEIVC68H107N17O25
HIV-1 MN ENV-92;NQSSGGDPEIVMHSFC67H101N19O25S
HIV-1 MN ENV-93;GGDPEIVMHSFNCGGC63H94N18O22S2
HIV-1 MN ENV-94;EIVMHSFNCGGEFFYC82H110N18O23S2
HIV-1 MN ENV-95;HSFNCGGEFFYCNTSC75H97N19O24S2
HIV-1 MN ENV-96;CGGEFFYCNTSPLFNC77H103N17O23S2
HIV-1 MN ENV-97;FFYCNTSPLFNSTWNC87H113N19O24S
HIV-1 MN ENV-98;NTSPLFNSTWNGNNTC71H103N21O26
HIV-1 MN ENV-99;LFNSTWNGNNTWNNTC78H107N23O26
HIV-1 MN gp160 Fragment 02;LLMICSATC36H66N8O11S2
HIV-1 MN gp160 Fragment 03;CSATEKLWVC46H73N11O14S
HIV-1 MN gp160 Fragment 04;EKLWVYYGVPVWKEATTTC105H152N22O28
HIV-1 MN ENV-26;EQMHEDIISLWDQSLC80H122N20O28S
HIV-1 MN ENV-3;NYQHWWGWGTMLLGLC90H120N22O20S
HIV-1 MN ENV-30;PCVKLTPLCVTLNCTC69H121N17O20S3
HIV-1 MN ENV-31;LTPLCVTLNCTDLRNC70H122N20O23S2
HIV-1 MN ENV-32;CVTLNCTDLRNTTNTC65H113N21O26S2
HIV-1 MN ENV-33;NCTDLRNTTNTNNSTC62H105N23O29S
HIV-1 MN ENV-34;LRNTTNTNNSTANNNC62H105N25O28
HIV-1 MN ENV-35;TNTNNSTANNNSNSEC57H92N22O31
HIV-1 MN ENV-37;NNNSNSEGTIKGGEMC59H98N20O27S
HIV-1 MN ENV-38;NSEGTIKGGEMKNCSC60H103N19O25S2
HIV-1 MN ENV-39;TIKIGGEMKNCSFNITC75H126N20O24S2
HIV-1 MN ENV-4;WWGWGTMLLGLLMICC86H126N18O17S3
HIV-1 MN ENV-40;GEMKNCSFNITTSIRC70H117N21O24S2
HIV-1 MN ENV-41;NCSFNITTSIRDKMQC72H120N22O25S2
HIV-1 MN ENV-42;NITTSIRDKMQKEYAC76H128N22O26S
HIV-1 MN ENV-43;SIRDKMQKEYALLYKC85H140N22O24S
HXB2 gag #102/aa405-419;CRAPRKKGCWKCGKEC73H124N26O18S3
HXB2 gag #101/aa401-415;TARNCRAPRKKGCWKC74H127N29O18S2
HXB2 gag #100/aa397-411;KEGHTARNCRAPRKKC71H126N30O20S
HXB2 gag #10;ASRELERFAVNPGLL
HXB2 gag #1/aa1-15;MGARASVLSGGELDR
Human prepro-gamma-tryptase (192-206);CRRDYPGPGGSILQPC69H110N22O21S
H-Tyr-Val-Ala-Asp-AFC;YVAD-AFCC31H34F3N5O9
HIV-1 MN ENV-21;QEVELVNVTENFNMWC82H122N20O27S
HIV-1 MN ENV-210;GRAILHIPTRIRQGLC75H133N27O18
HIV-1 MN ENV-211;LHIPTRIRQGLERALC78H137N27O20
HIV-1 MN ENV-212;TRIRQGLERALLC61H112N22O17
HIV-1 MN ENV-22;LVNVTENFNMWKNNMC81H124N22O24S2
HIV-1 MN ENV-23;TENFNMWKNNMVEQMC81H122N22O26S3
HIV-1 MN ENV-24;NMWKNNMVEQMHEDIC80H123N23O26S3
HIV-1 MN ENV-25;NNMVEQMHEDIISLWC80H123N21O26S2
HMGA N-Terminal Fragment;GAGQPSTSAQGQC42H69N15O19
HIV-1 Protease Substrate, chromogenic;Ac-RKILF(4-NO2)LDG-NH2C47H78N14O13
HIV-1 MN gp160 Fragment 17;NDSTSYRLISCNTSVC67H110N20O27S
HIV-1 MN gp160 Fragment 16;LYKLDIVSIDNDSTSYRLISC103H167N25O35
HIV-1 MN gp160 Fragment 15;REKMQKEYALLYKLDIVSIDC111H183N27O33S
HIV-1 MN gp160 Fragment 08;NFNMWKNNMVEQMHEDIISKC108H166N30O33S3
HIV-1 MN gp160 Fragment 07;ELVNVTENFNMWKC73H110N18O22S
HIV-1 MN gp160 Fragment 05;VPVWKEATTTLFCASDAKAYC101H153N23O30S
HIV-1 MN ENV-44;KMQKEYALLYKLDIVC87H143N19O23S
HIV-1 MN ENV-45;EYALLYKLDIVSIDNC82H129N17O26
HIV-1 MN ENV-46;LYKLDIVSIDNDSTSC73H119N17O28
HIV-1 MN ENV-47;DIVSIDNDSTSYRLIC73H119N19O28
HIV-1 MN ENV-48;IDNDSTSYRLISCNTC69H112N20O28S
HIV-1 MN ENV-49;STSYRLISCNTSVITC69H117N19O25S
HIV-1 MN ENV-5;GTMLLGLLMICSATEC66H117N15O21S3
HIV-1 MN ENV-50;RLISCNTSVITQACPC66H116N20O22S2
HIV-1 MN ENV-51;CNTSVITQACPKISFC69H114N18O22S2
HIV-1 MN ENV-52;VITQACPKISFEPIPC76H123N17O21S
HIV-1 MN ENV-53;ACPKISFEPIPIHYCC80H120N18O20S2
HIV-1 MN ENV-54;ISFEPIPIHYCAPAGC76H111N17O20S
HIV-1 MN ENV-56;HYCAPAGFAILKCNDC72H107N19O20S2
HIV-1 MN ENV-58;AILKCNDKKFSGKGSC69H118N20O21S
HIV-1 MN ENV-57;PAGFAILKCNDKKFSC75H119N19O20S
H-Phe-Arg-AFC;FR-AFCC25H27F3N6O4
Human Myocilin/TIGR Fragment (188-204);TRDTARAVPPGSREVSTC73H126N26O27
HIV-1 MN ENV-36;NSTANNNSNSEGTIKC59H99N21O28
HXB2 gag #103;RKKGCWKCGKEGHQM
83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100
Copyright 2019 © ChemicalBook. All rights reserved